Evaluation of Adherence and Therapeutic Effectiveness of BiPAP With Bi-Flex Versus CPAP in Children With Obstructive Sleep Apnea
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 60
- 试验地点
- 2
- 主要终点
- Minutes of Use Per Night at Month 1
研究概览
简要总结
Context: The obstructive sleep apnea syndrome (OSAS), i.e., snoring with difficulty breathing during sleep, is common in children. Continuous positive airway pressure (CPAP) therapy is the usual treatment for children who do not improve following surgery. However, CPAP is uncomfortable and is often not tolerated. We therefore plan to study a modification of bilevel positive airway pressure therapy, BiPAP with Bi-Flex that may be more comfortable.
Objectives: The primary objective of this study is to determine whether BiPAP with Bi-Flex results in improvement in adherence as compared to CPAP. The secondary objective is to determine whether Bi-Flex has similar therapeutic efficacy compared to CPAP, as determined by sleep study. Additional objectives include comparing CPAP and Bi-Flex effects on comfort and determining which parameters predict adherence.
Study Design/Setting/Participants: A single center, randomized controlled double-blind study of Bi-Flex vs CPAP use in children with OSAS over a 3 month period.
Intervention: Bi-Flex vs CPAP Study Measures: Objective compliance recordings, sleep study results, subjective questionnaire results. .
详细描述
STUDY RATIONALE The obstructive sleep apnea syndrome (OSAS) affects approximately 2% of children and results in significant morbidity. Continuous positive airway pressure (CPAP) is the standard therapy for children who fail tonsillectomy and adenoidectomy, or for those in whom surgery is not indicated. However, CPAP is uncomfortable and is often not tolerated by children. Thus, a more comfortable technology that would enhance adherence would be highly desirable. This proposal aims to compare a new technology, Bi-Flex, to standard CPAP therapy.
Bilevel positive airway pressure (BiPAP): Whereas conventional CPAP therapy delivers a constant, steady pressure during inspiration and expiration, BiPAP therapy is intended to respond to both inspiration and expiration by the patient and to deliver a set amount of pressure when the patient begins spontaneous inhalation, and decreasing pressure when exhalation begins. Exhaling against lower pressure is thought to be more comfortable for most patients than the continuous pressure delivered by conventional CPAP therapy, although it has not been shown objectively to improve adherence. The BiPAP waveform is fixed in that it provides for set inspiratory and expiratory pressures. For example, the patient's clinically prescribed BiPAP pressures may be set at an Inspiratory Positive Airway Pressure (IPAP) =12 cm water (H2O), and Expiratory Positive Airway Pressure (EPAP) = 8 cm H2O.
The Bi-Flex® feature provides a variation of conventional BiPAP that provides a reduction in the inspiratory positive airway pressure (IPAP) provided toward the end of the inspiratory portion of the breathing cycle when the patient's inspiratory airflow normally diminishes, compared with the level of pressure provided during the majority of inspiration, and also allows reduction in the expiratory positive airway pressure (EPAP) during the initial portion of exhalation compared with that provided during the latter portion of expiration. The purpose of this modification is to provide pressure relief for the patient to smooth the transition period between the end of IPAP and the beginning of EPAP to allow for a more comfortable delivery of PAP therapy. Because Bi-Flex provides both a lower expiratory pressure and pressure relief, it has the potential to be the most comfortable mode of positive pressure therapy delivery available, and therefore to improve adherence. However, there have been no studies of adherence to therapy using Bi-Flex in either children or adults.
STUDY OBJECTIVES
- To determine whether BiPAP with Bi-Flex as compared to CPAP results in improvement in adherence of > 30 minutes a night averaged over 3 months of home use.
- To determine whether BiPAP with Bi-Flex as compared to CPAP results in a lower study dropout rate.
- To determine whether Bi-Flex has similar therapeutic efficacy compared to CPAP, as determined by polysomnographic measurements of OSAS.
- To determine whether Bi-Flex, compared to CPAP, results in improved subjective comfort and improved quality of life.
- To determine whether objective parameters (including demographic and polysomnographic variables) or subjective parameters predict adherence.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Care Provider, Investigator)
入排标准
- 年龄范围
- 2 Years 至 16 Years(Child)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Males or females aged 2 to 16 years.
- •OSAS diagnosed on polysomnography.
- •Positive airway pressure therapy indicated by patient's physician because surgery was either contraindicated or ineffective.
- •No plans for upper airway surgery in the next 3 months.
排除标准
- •Age less than 2 years, as infants and toddlers have different pulmonary mechanics from older children, and may require intense behavioral modification programs prior to CPAP use.
- •Age greater or equal to 16 years, as results may be similar to adult studies in these older patients.
- •Previous use of CPAP / bilevel ventilation.
- •Unable to read / understand English. -
结局指标
主要结局
Minutes of Use Per Night at Month 1
时间窗: 1 month
The number of minutes of use per night at month 1.
Minutes of Use Per Night at Month 3
时间窗: 3 Months
The number of minutes of use per night at Month 3.
Change in Minutes of Use Per Night From Month 1 to Month 3
时间窗: month 1, month 3
minutes of use per night at Month 3 minus minutes of use per night at Month 1
次要结局
- Change in Apnea Hypopnea Index (AHI; Number of Apneas and Hypopneas Per Hour of Sleep) From Month 1 to Month 3(3 months)
- Obstructive Sleep Apnea (OSA) 18 Score(3 months)
- Change in NOSE Scale Score From Month 1 to Month 3(3 months)
- Pediatric Quality of Life (PedQL)(3 months)
- Drop Out Rate(3 months)
- Change in ESS From Month 1 to Month 3(3 months)
研究者
Ignacio Tapia, MD
Principal Investigator
Children's Hospital of Philadelphia
